Real-World

Evidence & Economics

Evidence - Intermountain Healthcare 

  • 83% of nurses recommended the adoption of MedLite ID.

  • 78% of nurses reported increased overall patient safety and care.

  • 81% of nurses noticed improved efficiency associated with line tracing.

  • 87% of nurses claimed reduced stress associated with line tracing.

Evidence - Utah Tech (formerly DSU)

  • 100% decreased the time it took them to find the medication line with an overall time savings of 34%, or nearly one minute.

  • 100% expressed how the MedLite ID reduced their stress levels.

  • Average time savings per trial was 57.3 seconds with just 4 lines.

  • 51% nursing productivity/ efficiency improvement.

Evidence - MedLite Tape Study

Icon-IV-line

  • 80% of the used rolls tested positive for pathogens.

  • 16 of the 36 bacteria and fungi found were pathogenic.

  • Two bacteria identified as critical or serious by the World Health Organization.

MedLite Evidence Summary

What Can MedLite Smart Lites Do For You?


  • 78% Increase in Patient Safety
  • 34% Reduction in Time to Identify
  • 81% Improved Efficency
  • 87% Nurse Stress Reduction

83% Nurse Adoption

Request a Trial

Best Practices for multiple IV co-administration infusions.

From AHRQ: An Inadvertent Bolus of Norepinephrine. Administration of multiple IV infusions is ubiquitous in the ICU, and there are several established safety parameters associated with medication concentration, dosing, and pump programming. The physical dexterity required for administering multiple IV infusions concurrently is underappreciated, and lack thereof can, in fact, lead to serious harm.  AHRQ addressed this issue in a recent article, including recognizing risks associated with medication administration, the most frequent types of IV medical errors in the ICU, and best practices for the co-administration of multiple IV infusions. (Reprinted with permission.)

Eligible for

IV-Pump-Blog--Image
IV-V3-photo-Circle-Graphic

MedLite ID & Infectious Disease

Reduce exposure to infectious disease by up to two hours per day per 12-hour shift. 

  • Healthcare workers can be exposed more often due to numerous infected individuals. Reducing the frequency and intensity of exposure to infectious diseases list MRSA or SARs-CoV-2 might reduce the infectious dose and result in less severe cases.Icon-Covid-Checklist

  • It is reasonable to consider 15 minutes of exposure as prolonged exposure to some infectious diseases. This could refer to a single exposure to one infected individual or several briefer exposures to several individuals, adding up to at least 15 minutes during a 24-hour period (CDC).

  • Return to work 5-20 days since symptoms first appeared, and 24 hours from last fever and symptoms (depending on your immunocompromised state.) (CDC)

$1,500 Per Day Savings

Adding MedLite ID converts a daily loss to a daily savings


  • 78% of ADE Costs Not Reimbursed
  • 56% of ADEs are Infusion Related
  • 19 ADEs per 1000 ICU Patient Days
  • 17+ Drugs Per Day in ICU
  • $2,200 Lost per Day per 100 Beds
  • $5,185 Average ADE Costs Per Event
  • 15% of Infusion ADE = Wrong Route Errors

Avoid $2,200 Lost Per Day

Request a Trial

Economics 

What is the cost of doing nothing?  We can convert an estimated $2,200 loss per day to $1,500 per day in savings after paying for the MedLite ID solution

  • A 100-bed hospital could experience about 153 infusion ADEs annually.
  • This is an annual loss of $790K - a loss that can be avoided.
  • After paying for MedLite ID, a net $500K+ in savings is possible.

Possible IV ADE Loss Per 100 Beds

153-IV-ADE-Possible

Possible Savings Per
100 Beds

553k-YearSavings